Status:
UNKNOWN
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Clostridium Difficile Infections
Eligibility:
All Genders
18+ years
Brief Summary
Clostridioides difficile (formerly Clostridium) is a bacterium found in the form of spores (resistance form) in the environment to which patients may be exposed. This bacterium used to belong to the C...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- Patients hospitalized in a department of GH Paris Saint-Joseph with a microbiologically documented Clostridioides difficile infection or a microbiologically documented Clostridioides difficile recurrence.
- Patient to be treated for Clostridioides difficile infection
- French-speaking patient
- Patients who do not object to their participation in the study
Exclusion
- Patients under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Pregnant or breast-feeding patient
Key Trial Info
Start Date :
September 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 17 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06030245
Start Date
September 18 2023
End Date
November 17 2025
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Hôpital Saint-Joseph
Paris, France, 75014